MeSH tree: B04.820.480.937.600.670
In a new study, wastewater surveillance for multiple pathogens at five different sites identified local trends that were not captured in larger surveillance programs, and some sites used the data to inform efforts to prevent ...
Apr 9, 2025
0
53
An Australian-first study demonstrating the effectiveness of a new immunization against respiratory syncytial virus (RSV) for babies found it to be almost 90% effective in reducing hospitalization rates and helped more than ...
Mar 28, 2025
0
19
Five years after the World Health Organization declared COVID-19 a global pandemic, infectious disease experts continue to draw on its lessons for future disasters.
Mar 12, 2025
0
11
In Europe, ten people died from measles in 2024, and the US has had several major outbreaks. Bird flu has affected dairy herds in 17 US states from North Carolina to California and has just been reported in cats. So far, ...
Mar 11, 2025
0
17
In October, Stanford University professor Jay Bhattacharya hosted a conference on the lessons of COVID-19 in order "to do better in the next pandemic." He invited scholars, journalists, and policy wonks who, like him, have ...
Feb 25, 2025
0
20
People with flu-like symptoms are pouring into Miami-Dade and Broward urgent care and ERs as infections across the country reach levels not seen in a decade. And for the first time since the start of the pandemic in 2020, ...
Feb 24, 2025
0
175
A vaccination program has cut hospital admissions for a respiratory virus among older people in Scotland by nearly two-thirds.
Feb 17, 2025
0
129
A deluge of disinformation about a flu-like virus called HMPV is stoking anti-China sentiment across Asia and spurring unfounded concerns of renewed lockdowns, despite experts dismissing comparisons with the COVID-19 pandemic ...
Feb 11, 2025
0
21
Influenza A virus particles strategically adapt their shape—to become either spheres or larger filaments—to favor their ability to infect cells depending on environmental conditions, according to a new study from National ...
Feb 10, 2025
0
21
A nasal vaccine for COVID-19—based on technology developed at Washington University in St. Louis—is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug application from Ocugen, Inc. was ...
Feb 5, 2025
0
39
